Category: Systemic mastocytosis

Home / Systemic mastocytosis

Categories

Avapritinib has been approved by the FDA for advanced systemic mastocytosis

August 2021: The FDA approved avapritinib (AyvakitTM, Blueprint Medicines Corp.) for adult patients with advanced systemic mastocytosis (AdvSM), which includes aggressive systemic mastocytosis (ASM), ...

We Are Online! Chat With Us!
Scan the code